AG Renwick

950 total citations
26 papers, 787 citations indexed

About

AG Renwick is a scholar working on Pediatrics, Perinatology and Child Health, Oncology and Pharmacology. According to data from OpenAlex, AG Renwick has authored 26 papers receiving a total of 787 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pediatrics, Perinatology and Child Health, 7 papers in Oncology and 7 papers in Pharmacology. Recurrent topics in AG Renwick's work include Drug Transport and Resistance Mechanisms (7 papers), Pharmacological Effects and Toxicity Studies (7 papers) and Pharmacogenetics and Drug Metabolism (6 papers). AG Renwick is often cited by papers focused on Drug Transport and Resistance Mechanisms (7 papers), Pharmacological Effects and Toxicity Studies (7 papers) and Pharmacogenetics and Drug Metabolism (6 papers). AG Renwick collaborates with scholars based in United Kingdom and United States. AG Renwick's co-authors include CF George, DG Waller, DR Robertson, VF Challenor, Ubaldo J. Martin, ST Holgate, Robert D. Richards, Nicholas C.P. Cross, John Fleming and John McEwen and has published in prestigious journals such as European Respiratory Journal, British Journal of Clinical Pharmacology and Steroids.

In The Last Decade

AG Renwick

26 papers receiving 747 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
AG Renwick United Kingdom 13 244 220 177 116 104 26 787
DG Waller United Kingdom 17 241 1.0× 229 1.0× 178 1.0× 140 1.2× 137 1.3× 28 920
George R. Avant United States 16 362 1.5× 249 1.1× 132 0.7× 39 0.3× 152 1.5× 30 1.2k
Edward J. Randinitis United States 18 232 1.0× 265 1.2× 371 2.1× 62 0.5× 194 1.9× 43 1.3k
Yukinao Kohda Japan 19 216 0.9× 150 0.7× 253 1.4× 29 0.3× 139 1.3× 115 1.3k
Eva Bredberg Sweden 17 313 1.3× 174 0.8× 67 0.4× 114 1.0× 73 0.7× 20 1.1k
Eva Steiness Denmark 20 108 0.4× 130 0.6× 138 0.8× 66 0.6× 166 1.6× 75 1.3k
John A. Ziemniak United States 15 88 0.4× 196 0.9× 133 0.8× 36 0.3× 115 1.1× 28 640
A. J. McLean Australia 17 101 0.4× 126 0.6× 80 0.5× 89 0.8× 142 1.4× 45 914
Harri Luurila Finland 12 399 1.6× 277 1.3× 236 1.3× 33 0.3× 140 1.3× 20 897
D. Kadar Canada 15 293 1.2× 129 0.6× 125 0.7× 21 0.2× 148 1.4× 29 729

Countries citing papers authored by AG Renwick

Since Specialization
Citations

This map shows the geographic impact of AG Renwick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by AG Renwick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites AG Renwick more than expected).

Fields of papers citing papers by AG Renwick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by AG Renwick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by AG Renwick. The network helps show where AG Renwick may publish in the future.

Co-authorship network of co-authors of AG Renwick

This figure shows the co-authorship network connecting the top 25 collaborators of AG Renwick. A scholar is included among the top collaborators of AG Renwick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with AG Renwick. AG Renwick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Waller, DG, et al.. (1995). The effect of selegiline on the peripheral pharmacokinetics of levodopa in young volunteers.. British Journal of Clinical Pharmacology. 40(4). 404–406. 5 indexed citations
2.
Richards, Robert D., et al.. (1992). Inhaled histamine increases the rate of absorption of sodium cromoglycate from the lung.. British Journal of Clinical Pharmacology. 33(3). 337–341. 2 indexed citations
3.
Honeywell, Richard J., et al.. (1992). The effect of respiratory manoeuvres and pharmacological agents on the pharmacokinetics of nedocromil sodium after inhalation.. British Journal of Clinical Pharmacology. 33(4). 431–438. 4 indexed citations
4.
Waller, DG, et al.. (1991). Oral amino acids and gastric emptying: an investigation of the mechanism of levodopa‐induced gastric stasis.. British Journal of Clinical Pharmacology. 32(6). 771–773. 9 indexed citations
5.
Waller, DG, et al.. (1991). Gastric emptying in healthy volunteers after multiple doses of levodopa.. British Journal of Clinical Pharmacology. 32(6). 691–695. 15 indexed citations
6.
Renwick, AG, et al.. (1991). Ethnic differences in the pharmacokinetics of oral nifedipine.. British Journal of Clinical Pharmacology. 31(4). 399–403. 52 indexed citations
7.
Robertson, DR, AG Renwick, Nicholas C.P. Cross, et al.. (1990). The influence of levodopa on gastric emptying in man.. British Journal of Clinical Pharmacology. 29(1). 47–53. 63 indexed citations
8.
Honeywell, Richard J., et al.. (1990). The pharmacokinetics of doxazosin in patients with hypertension and renal impairment.. British Journal of Clinical Pharmacology. 29(4). 417–422. 4 indexed citations
9.
Richards, Robert D., et al.. (1989). Deep inspiration increases the absorption of inhaled sodium cromoglycate.. British Journal of Clinical Pharmacology. 27(6). 861–865. 10 indexed citations
10.
Robertson, DR, et al.. (1989). The effect of age on the pharmacokinetics of levodopa administered alone and in the presence of carbidopa.. British Journal of Clinical Pharmacology. 28(1). 61–69. 95 indexed citations
11.
Challenor, VF, DG Waller, AG Renwick, & CF George. (1989). Slow release nifedipine plus atenolol in chronic stable angina pectoris.. British Journal of Clinical Pharmacology. 28(5). 509–516. 7 indexed citations
12.
Renwick, AG, et al.. (1988). The pharmacokinetics of oral nifedipine‐a population study.. British Journal of Clinical Pharmacology. 25(6). 701–708. 40 indexed citations
13.
Richards, Robert D., et al.. (1988). Inhalation rate of sodium cromoglycate determines plasma pharmacokinetics and protection against AMP-induced bronchoconstriction in asthma. European Respiratory Journal. 1(10). 896–901. 26 indexed citations
14.
Challenor, VF, et al.. (1987). Food and nifedipine pharmacokinetics.. British Journal of Clinical Pharmacology. 23(2). 248–249. 16 indexed citations
15.
George, CF, et al.. (1986). A comparison of isoxicam pharmacokinetics in young and elderly subjects.. British Journal of Clinical Pharmacology. 22(S2). 129S–134S. 1 indexed citations
16.
Waller, DG, et al.. (1984). The first pass metabolism of nifedipine in man.. British Journal of Clinical Pharmacology. 18(6). 951–954. 105 indexed citations
17.
Renwick, AG, et al.. (1983). The absorption and conjugation of methyldopa in patients with coeliac and Crohn's diseases during treatment.. British Journal of Clinical Pharmacology. 16(1). 77–83. 9 indexed citations
18.
Renwick, AG, et al.. (1983). Acebutolol pharmacokinetics in renal failure.. British Journal of Clinical Pharmacology. 16(3). 253–258. 9 indexed citations
19.
Waller, DG, C. Smith, AG Renwick, & CF George. (1982). Intravenous propranolol in patients with inflammation.. British Journal of Clinical Pharmacology. 13(4). 577–578. 6 indexed citations
20.
George, CF, et al.. (1980). Pharmacokinetics of methyldopa in gastrointestinal disease [proceedings]. British Journal of Clinical Pharmacology. 9(1). 109P–110P. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026